3rd-4th December 2020

MarketsandMarkets Digital Event on Orphan Drugs and Rare Diseases

New medicine for orphan and Rare diseases has the capability to undoubtedly impact the lives of patients, where historically there were few or no treatments have been provided to control the sickness. The Orphan Drug Act (ODA) established in 1983 compelled producers to expand scale to treat uncommon/orphan diseases, and the orphan drug panorama has advanced drastically. Approvals for orphan drugs has doubled in the past decade, and there are over 500 applicants in the pipeline for orphan diseases.

MarketsandMarkets Digital Event on Orphan Drugs and Rare Diseases scheduled to be held on 3rd -4th December 2020 will provide valuable and necessary platform for uplifting knowledge at the forefront of drug analysis. Over the course of the conference, internationally renowned speakers can describe how their analysis journeys have developed the response towards up to date challenges. The attending specialists and trade partners will offer an incredible networking expertise.
 

This conference will gather scientists, researchers, entrepreneurs, academicians, medical officers, CEO’s, CSO’s and technologists from everywhere around the globe to discuss on the newest scientific advances within the field of rare diseases & orphan drugs that facilitate to form current and future challenges in drug analysis.

WHAT TO EXPECT
Key Highlights
  • The growth of orphan drugs for rare diseases
  • Challenges and opportunities in treatment
  • Improving clinical trials for rare diseases
  • Classification by types of rare diseases and therapy options
  • Commercialization and pricing strategies for orphan drugs
  • Discussion on current regulatory measures for manufacturing orphan drugs
Why Attend?
  • 100+ experts attending
  • Participate in constructive discussion with leading industry experts and decision-makers from pharmaceutical manufacturers who will tackle the most important issues in Rare disease diagnosis.
  • Best opportunity to showcase your work and research in front of industry leaders.
  • Develop your skills by learning new competencies and acquire knowledge from pioneers all around the world.
CONFERENCE SPEAKERS
Speakers
Monica Vinhas de Souza, MD, PhD

Monica Vinhas de Souza, MD, PhD

Executive Member of the research and ethics committee
Hospital de Clínicas de Porto Alegre (HCPA)

Monica Vinhas de Souza, MD, PhD

Executive Member of the research and ethics committee
Hospital de Clínicas de Porto Alegre (HCPA)
Stephen Groft

Stephen Groft

Senior Advisor to the Director NCATS,
NIH

Stephen Groft

Senior Advisor to the Director NCATS,
NIH
Stavros Ntogiakos

Stavros Ntogiakos

Regional Head of Rare Ocular Disease
Novartis

Stavros Ntogiakos

Regional Head of Rare Ocular Disease
Novartis
Sebastian Waldmeier

Sebastian Waldmeier

Brand Director Gene Therapy/Luxturna, Region Europe
Novartis

Sebastian Waldmeier

Brand Director Gene Therapy/Luxturna, Region Europe
Novartis
Marcus Guardian

Marcus Guardian

Chief Operating Officer
EUnetHTA

Marcus Guardian

Chief Operating Officer
EUnetHTA
PAST EVENT GALLERY